Australian Clinical Labs Ltd (ACL)

Currency in AUD
2.76
-0.04(-1.43%)
Delayed Data·
ACL Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
ACL is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
2.762.79
52 wk Range
2.473.86
Key Statistics
Bid/Ask
2.76 / 2.77
Prev. Close
2.8
Open
2.79
Day's Range
2.76-2.79
52 wk Range
2.47-3.86
Volume
36.87K
Average Volume (3m)
1.04M
1-Year Change
-3.56%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.60
Upside
+30.43%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Australian Clinical Labs Ltd Company Profile

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Compare ACL to Peers and Sector

Metrics to compare
ACL
Peers
Sector
Relationship
P/E Ratio
16.8x23.9x−0.6x
PEG Ratio
0.40−0.020.00
Price/Book
3.2x1.7x2.6x
Price / LTM Sales
0.7x1.2x3.3x
Upside (Analyst Target)
25.0%15.6%39.1%
Fair Value Upside
Unlock21.5%5.4%Unlock

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.60
(+30.43% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
4.46%
Industry Median 3.45%
Annualised payout
0.13
Paid unevenly
5-Years Growth
-2.86%
Growth Streak

Earnings

Latest Release
Aug 25, 2025
EPS / Forecast
0.12 / --
Revenue / Forecast
372.10M / --
EPS Revisions
Last 90 days

ACL Income Statement

People Also Watch

0.895
HLS
-1.65%
26.240
WDS
+0.34%
1.385
AX1
-0.36%
2.160
VEA
+4.85%
212.40
CSL
-0.14%

FAQ

What Stock Exchange Does Australian Clinical Labs Trade On?

Australian Clinical Labs is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Australian Clinical Labs?

The stock symbol for Australian Clinical Labs is "ACL."

What Is the Australian Clinical Labs Market Cap?

As of today, Australian Clinical Labs market cap is 524.73M.

What Is Australian Clinical Labs's Earnings Per Share (TTM)?

The Australian Clinical Labs EPS (TTM) is 0.17.

From a Technical Analysis Perspective, Is ACL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Australian Clinical Labs Stock Split?

Australian Clinical Labs has split 0 times.

How Many Employees Does Australian Clinical Labs Have?

Australian Clinical Labs has 4700 employees.

What is the current trading status of Australian Clinical Labs (ACL)?

As of 29 Aug 2025, Australian Clinical Labs (ACL) is trading at a price of 2.76, with a previous close of 2.80. The stock has fluctuated within a day range of 2.76 to 2.79, while its 52-week range spans from 2.47 to 3.86.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.